Cargando…
Fast effectiveness of a solubilized low‐dose budesonide nasal spray in allergic rhinitis
BACKGROUND: Budesonide, a poorly water‐soluble corticosteroid, is currently marketed as a suspension. Budesolv is a novel aqueous formulation containing dissolved budesonide showing increased local availability in preclinical models. Budesolv contains ~85% less corticosteroid than the marketed compa...
Autores principales: | Zieglmayer, Petra, Schmutz, René, Lemell, Patrick, Unger‐Manhart, Nicole, Nakowitsch, Sabine, Goessl, Andreas, Savli, Markus, Zieglmayer, René, Prieschl‐Grassauer, Eva |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7540702/ https://www.ncbi.nlm.nih.gov/pubmed/32569395 http://dx.doi.org/10.1111/cea.13691 |
Ejemplares similares
-
Saponin Micelles Lead to High Mucosal Permeation and In Vivo Efficacy of Solubilized Budesonide
por: Nakowitsch, Sabine, et al.
Publicado: (2020) -
Sublingual house dust mite immunotherapy has no impact on decrease of circulating erythrocytes upon airway allergen challenge in allergic rhinitis
por: Jordakieva, Galateja, et al.
Publicado: (2017) -
Allergen challenge tests in allergen immunotherapy: State of the art
por: Zieglmayer, Petra, et al.
Publicado: (2023) -
Clinical efficacy of sublingual immunotherapy is associated with restoration of steady-state serum lipocalin 2 after SLIT: a pilot study
por: Roth-Walter, Franziska, et al.
Publicado: (2018) -
Quantification, epitope mapping and genotype cross-reactivity of hepatitis B preS-specific antibodies in subjects vaccinated with different dosage regimens of BM32
por: Tulaeva, Inna, et al.
Publicado: (2020)